Parker Institute for Cancer Immunotherapy (PICI) shared a post on LinkedIn:
“Yesterday, PICI convened a congressional briefing on Capitol Hill exploring the transformative potential of cancer vaccines.
We were honored to be joined by cancer vaccine recipients and advocates from across the country, Congresswoman Debbie Wasserman Schultz, Vinod Balachandran from Memorial Sloan Kettering Cancer Center, and other leaders committed to advancing research and innovation.
Several cancer vaccine recipients and PICI leaders also met with Senator Todd Young to discuss the promise of cancer vaccines and help raise awareness of their potential impact on patients.
Hearing these powerful stories and conversations serves as a reminder of what is possible when scientific innovation, patient advocacy, and public investment come together to drive progress against cancer. PICI is proud to help advance conversations and collaborations needed to bring these promising therapies to more patients.”
Other articles about PICI on OncoDaily.
